Navigation auf zora.uzh.ch

Search ZORA

ZORA (Zurich Open Repository and Archive)

Pharmacological upregulation of prostate-specific membrane antigen (PSMA) expression in prostate cancer cells

Kranzbühler, Benedikt; Salemi, Souzan; Umbricht, Christoph A; Müller, Cristina; Burger, Irene A; Sulser, Tullio; Eberli, Daniel (2018). Pharmacological upregulation of prostate-specific membrane antigen (PSMA) expression in prostate cancer cells. The Prostate, 78(10):758-765.

Abstract

BACKGROUND: Prostate-specific membrane antigen (PSMA)-based imaging and therapy are increasingly used for prostate cancer management. However, limitations are a low PSMA expression in certain patients. Androgen receptor axis inhibition can induce PSMA expression in vitro. We hypothesized that different approved compounds upregulate PSMA expression and tested their effect in vitro. METHODS: Androgen receptor (AR) expressing prostate cancer (LNCaP) and epithelial prostate cells (PNT1A) were treated for 7 days with enzalutamide, dutasteride, rapamycin, metformin, lovastatin, and acetylsalicylic acid (ASA). PSMA and AR protein expression was assessed using flow cytometry, immunocytochemistry and immunoblotting. Furthermore, uptake and internalization of $^{177}$Lu-PSMA-617 was performed. RESULTS: Enzalutamide and dutasteride led to a significant (both P < 0.05) upregulation of PSMA surface levels in LNCaP cells. In addition, treatment with rapamycin showed a non-significant trend toward PSMA upregulation. No changes were detected after treatment with vehicle, metformin, lovastatin, and ASA. Total PSMA protein expression was significantly enhanced after treatment with enzalutamide and rapamycin (both P < 0.05), whereas dutasteride led to a non-significant upregulation. Uptake of $^{177}$Lu-PSMA-617 was significantly increased after treatment of LNCaP with enzalutamide, dutasteride, and rapamycin (P < 0.05). In addition, internalization was significantly increased by enzalutamide and rapamycin (P < 0.05), and non-significantly increased by dutasteride. CONCLUSION: In conclusion, our data provide new insights into the effect of different approved pharmacological compounds that can markedly upregulate PSMA expression and radioligand uptake in vitro. Pharmacologically induced PSMA expression may prove useful to improve prostate cancer detection and to enhance anticancer effects in PSMA-based therapy.

Additional indexing

Item Type:Journal Article, refereed, original work
Communities & Collections:04 Faculty of Medicine > University Hospital Zurich > Urological Clinic
04 Faculty of Medicine > University Hospital Zurich > Clinic for Nuclear Medicine
Dewey Decimal Classification:610 Medicine & health
Scopus Subject Areas:Health Sciences > Oncology
Health Sciences > Urology
Uncontrolled Keywords:Urology, Oncology
Language:English
Date:6 April 2018
Deposited On:20 Jun 2018 12:19
Last Modified:21 May 2025 03:42
Publisher:Wiley-Blackwell Publishing, Inc.
ISSN:0270-4137
OA Status:Closed
Free access at:Publisher DOI. An embargo period may apply.
Publisher DOI:https://doi.org/10.1002/pros.23522
PubMed ID:29633296
Related Items:

Metadata Export

Statistics

Citations

Dimensions.ai Metrics
55 citations in Web of Science®
59 citations in Scopus®
Google Scholar™

Altmetrics

Downloads

0 downloads since deposited on 20 Jun 2018
0 downloads since 12 months

Authors, Affiliations, Collaborations

Similar Publications